CAPRICOR THERAPEUTICS
18.85
07-November-24 15:59:59
15 minutes delayed
Stocks
+0.62
+3.40%
Today's range
18.44 - 20.37
ISIN
N/A
Source
NASDAQ
-
19 Jan 2023 16:05:00 By Nasdaq GlobeNewswire
-
Capricor Announces Publication Highlighting New Advances for its Engineered Exosome Platform
12 Jan 2023 09:26:27 By Nasdaq GlobeNewswire
-
Capricor Therapeutics Reports Third Quarter 2022 Financial Results and Provides Corporate Update
10 Nov 2022 16:01:00 By Nasdaq GlobeNewswire
-
03 Nov 2022 16:01:00 By Nasdaq GlobeNewswire
-
06 Oct 2022 09:00:01 By Nasdaq GlobeNewswire
-
Capricor Therapeutics to Present at Upcoming Investor Conferences
07 Sep 2022 08:00:02 By Nasdaq GlobeNewswire
-
Capricor Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Update
10 Aug 2022 16:05:00 By Nasdaq GlobeNewswire
-
03 Aug 2022 08:00:01 By Nasdaq GlobeNewswire
-
19 Jul 2022 09:15:00 By Nasdaq GlobeNewswire
-
17 Jun 2022 09:00:00 By Nasdaq GlobeNewswire
-
Capricor Therapeutics Appoints Xavier Avat as Chief Business Officer
25 May 2022 09:00:02 By Nasdaq GlobeNewswire
-
Capricor Therapeutics to Present at the H.C. Wainwright Global Investment Conference
18 May 2022 09:00:01 By Nasdaq GlobeNewswire
-
Capricor Therapeutics Reports First Quarter 2022 Financial Results and Provides Corporate Update
10 May 2022 16:01:00 By Nasdaq GlobeNewswire
-
03 May 2022 08:30:00 By Nasdaq GlobeNewswire
-
Capricor Therapeutics to Participate in the Cantor Fitzgerald Rare Orphan Disease Summit
29 Mar 2022 09:00:01 By Nasdaq GlobeNewswire
-
28 Mar 2022 08:30:00 By Nasdaq GlobeNewswire
-
11 Mar 2022 08:00:00 By Nasdaq GlobeNewswire
-
10 Mar 2022 16:01:00 By Nasdaq GlobeNewswire
-
03 Mar 2022 09:15:00 By Nasdaq GlobeNewswire